These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20059975)
41. The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. Jonas A; Steinmetz A; Churgay L J Biol Chem; 1993 Jan; 268(3):1596-602. PubMed ID: 8420935 [TBL] [Abstract][Full Text] [Related]
42. Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. Han JM; Jeong TS; Lee WS; Choi I; Cho KH J Lipid Res; 2005 Mar; 46(3):589-96. PubMed ID: 15716588 [TBL] [Abstract][Full Text] [Related]
43. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1. Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798 [TBL] [Abstract][Full Text] [Related]
44. Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities. Cho KH; Bahuguna A; Lee Y; Lee SH; Dominguez-Horta MDC; Martinez-Donato G Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791598 [TBL] [Abstract][Full Text] [Related]
46. Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish. Park KH; Kim JM; Cho KH Mol Nutr Food Res; 2014 Jul; 58(7):1537-45. PubMed ID: 24863413 [TBL] [Abstract][Full Text] [Related]
47. Cadmium exposure exacerbates severe hyperlipidemia and fatty liver changes in zebrafish via impairment of high-density lipoproteins functionality. Kim JY; Kim SJ; Bae MA; Kim JR; Cho KH Toxicol In Vitro; 2018 Mar; 47():249-258. PubMed ID: 29197506 [TBL] [Abstract][Full Text] [Related]
48. Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins. Caiazza D; Jahangiri A; Rader DJ; Marchadier D; Rye KA Biochemistry; 2004 Sep; 43(37):11898-905. PubMed ID: 15362876 [TBL] [Abstract][Full Text] [Related]
49. Ethanol and water extract of purple sweet potato exhibits anti-atherosclerotic activity and inhibits protein glycation. Park KH; Kim JR; Lee JS; Lee H; Cho KH J Med Food; 2010 Feb; 13(1):91-8. PubMed ID: 20136441 [TBL] [Abstract][Full Text] [Related]
50. Structural and functional changes in high-density lipoprotein induced by chemical modification. Murakami T; Okamoto H; Kim H Biomater Sci; 2015 May; 3(5):712-5. PubMed ID: 26222589 [TBL] [Abstract][Full Text] [Related]
51. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells. Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173 [TBL] [Abstract][Full Text] [Related]
52. Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis. Jayaraman S; Cavigiolio G; Gursky O Biochem J; 2012 Mar; 442(3):703-12. PubMed ID: 22150513 [TBL] [Abstract][Full Text] [Related]
53. Pharmacological intervention using reconstituted high-density lipoprotein changes in the lipid profile in spontaneously hypersensitive rats. Imaizumi S; Kiya Y; Miura S; Zhang B; Matsuo Y; Uehara Y; Rye KA; Saku K Clin Exp Hypertens; 2010 May; 32(3):202-8. PubMed ID: 20504129 [TBL] [Abstract][Full Text] [Related]
54. A reconstituted high density lipoprotein containing the V156E mutant of apolipoprotein A-I exhibits anti-atherosclerotic activity in Apo-E deficient mice. Cho KH J Atheroscler Thromb; 2009 Jun; 16(3):217-29. PubMed ID: 19638715 [TBL] [Abstract][Full Text] [Related]
55. Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins. Lagerstedt JO; Cavigiolio G; Budamagunta MS; Pagani I; Voss JC; Oda MN J Biol Chem; 2011 Jan; 286(4):2966-75. PubMed ID: 21047795 [TBL] [Abstract][Full Text] [Related]
56. Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes. Correa Y; Ravel M; Imbert M; Waldie S; Clifton L; Terry A; Roosen-Runge F; Lagerstedt JO; Moir M; Darwish T; Cárdenas M; Del Giudice R Protein Sci; 2024 May; 33(5):e4987. PubMed ID: 38607188 [TBL] [Abstract][Full Text] [Related]
57. Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins. Wilson CJ; Das M; Jayaraman S; Gursky O; Engen JR Biochemistry; 2018 Jul; 57(30):4583-4596. PubMed ID: 30004693 [TBL] [Abstract][Full Text] [Related]
58. Characterization of apolipoprotein A-I structure using a cysteine-specific fluorescence probe. Tricerri MA; Behling Agree AK; Sanchez SA; Jonas A Biochemistry; 2000 Nov; 39(47):14682-91. PubMed ID: 11087425 [TBL] [Abstract][Full Text] [Related]
60. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation. Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]